MGlu5 receptors and cellular prion protein mediate amyloid-β- facilitated synaptic long-term depression in vivo

159Citations
Citations of this article
158Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

NMDA-type glutamate receptors (NMDARs) are currently regarded as paramount in the potent and selective disruption of synaptic plasticity by Alzheimer's disease amyloid β-protein (Aβ). Non-NMDAR mechanisms remain relatively unexplored. Here we describe how Aβ facilitates NMDAR-independent long-term depression of synaptic transmission in the hippocampus in vivo. Synthetic Aβ and Aβ in soluble extracts of Alzheimer's disease brain usurp endogenous acetylcholine muscarinic receptor-dependent long-term depression, to enable long-term depression that required metabotropic glutamate-5 receptors (mGlu5Rs). We also find that mGlu5Rs are essential for Aβ-mediated inhibition of NMDAR-dependent long-term potentiation in vivo. Blocking Aβ binding to cellular prion protein with antibodies prevents the facilitation of long-term depression. Our findings uncover an overarching role for Aβ-PrPC-mGlu5R interplay in mediating both LTD facilitation and LTP inhibition, encompassing NMDAR-mediated processes that were previously considered primary. © 2014 Macmillan Publishers Limited.

Cite

CITATION STYLE

APA

Hu, N. W., Nicoll, A. J., Zhang, D., Mably, A. J., O’Malley, T., Purro, S. A., … Rowan, M. J. (2014). MGlu5 receptors and cellular prion protein mediate amyloid-β- facilitated synaptic long-term depression in vivo. Nature Communications, 5. https://doi.org/10.1038/ncomms4374

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free